
CTVA · NYSE
Corteva is an agriculture-input company that sells seeds, crop traits and crop-protection products. It makes money through its Seed and Crop Protection businesses, serving growers and agricultural distribution channels. Its seed business includes products and intellectual property relevant to the reported dispute with Inari. The supplied evidence does not include reported financials, segment revenue, relative segment contributions or a measure of current scale, so those details cannot be stated from this material.
CTVA fell 1.73%, from $79.11 to $77.74 across the supplied period. Shares rose to $80.42 by Wednesday, then reversed course, closing lower on Thursday and Friday and falling again on Monday. The early-week advance was therefore more than erased by the subsequent decline. The evidence identifies Corteva and Inari’s settlement of their seed-deposit and intellectual-property lawsuit, but gives no publication date or indication that the settlement drove trading. It provides no market benchmark or broader sector context, and no clear catalyst for the share-price decline can be established from the supplied material.
Corteva fell $10.64, or 11.96%, from $88.95 to $78.31 over the period. The stock initially rose to $90.51 on July 29 before slipping to $89.34 on July 30, then dropped sharply to $78.71 on July 31 on heavy volume following its second-quarter report. The results delivered an EPS beat and a raised 2026 outlook, but sales fell 1% and profit declined as reduced seed volumes and competitive crop-protection pricing weighed on performance. Shares continued lower to $76.04 on August 3, then recovered to $78.31 on August 4, regaining only part of the post-earnings decline. No broader market driver is identified in the supplied evidence.